| Bioactivity | Meturedepa (AB 132) functions as a radiation sensitizer, enhancing the biological effects of radiation. When combined with suboptimal doses of X-ray radiation, this combined therapy achieves better outcomes in terms of tumor shrinkage compared to Meturedepa used alone. Meturedepa is applicable in the research of bronchogenic carcinoma[1]. |
| CAS | 1661-29-6 |
| Formula | C11H22N3O3P |
| Molar Mass | 275.28 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Velasco H A, et al. Combined use of AB‐132 (Meturedepa, Turloc) and X irradiation in the management of advanced bronchogenic carcinoma[J]. Cancer, 1964, 17(7): 841-849. |
Meturedepa
CAS: 1661-29-6 F: C11H22N3O3P W: 275.28
Meturedepa (AB 132) functions as a radiation sensitizer, enhancing the biological effects of radiation. When combined wi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.